Cladribine combined with cyclophosphamide and ... - Hem-aids.ru
Cladribine combined with cyclophosphamide and ... - Hem-aids.ru
Cladribine combined with cyclophosphamide and ... - Hem-aids.ru
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
1516<br />
CMC in untreated CLL<br />
T Robak et al<br />
26 B<strong>ru</strong>giatelli M, Claisse JF, Lenorm<strong>and</strong> B, Marabiro F, Callea V, Malloum<br />
K, Chevret S, Binet JL, Dighiero G, Travade P. Long term<br />
clinical outcome of B-cell chronic lymphocytic leukaemia patients<br />
in clinical remission phase evaluated at phenotypic level. BrJ<br />
Haematol 1997; 97: 113–118.<br />
27 Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results<br />
of cancer treatment. Cancer 1981; 47: 207–214.<br />
28 Duffy DR, Santner TJ. Confidence intervals for binomial parameter<br />
based on multistage tests. Biometrics 1987; 43: 81–93.<br />
29 Rummel MJ, Kafer G, Pfreundschuh M, Jager E, Reinhardt U,<br />
Mitrou PS, Hoelzer D, Bergmann L. Fludarabine <strong>and</strong> epi<strong>ru</strong>bicin<br />
in the treatment of chronic lymphocytic leukaemia: a German<br />
multicenter phase II study. Ann Oncol 1999; 10: 183–188.<br />
30 Zinzani PL, Magagnoli M, Moretti L, De Renzo A, Battista R, Zaccaria<br />
A, Guardigni L, Mazza P, Marra R, Ronconi F, Lauta VM,<br />
Bend<strong>and</strong>i M, Gherlinzoni F, Gentilini P, Ciccone F, Cellini C, Stefoni<br />
V, Ricciuti F, Gobbi M, Tura S. R<strong>and</strong>omized trial of fludarabine<br />
versus fludarabine <strong>and</strong> ida<strong>ru</strong>bicin as front line treatment in<br />
patients <strong>with</strong> indolent or mantle-cell lymphoma. J Clin Oncol<br />
2000; 18: 773–779.<br />
31 O’Brien S, Kantarjian H, Beran M, Freireich E, Kornblau S, Koller<br />
C, Lerner S, Gilbreath J, KeatingM. Fludarabine (FAMP) <strong>and</strong> <strong>cyclophosphamide</strong><br />
(CTX) therapy in chronic lymphocytic leukemia<br />
(CLL). Blood 1996; 88 (Suppl. 1): 480a (Abstr. 1910.)<br />
32 Flinn IW, Byrd JC, Morrison C, Janison J, Diehl LF, Murphy T,<br />
Piantadosi S, Seifter C, Ambinder RF, Vogelsang G, Grever MR.<br />
Fludarabine <strong>and</strong> <strong>cyclophosphamide</strong> <strong>with</strong> filgrastim support in<br />
patients <strong>with</strong> previously untreated indolent lymphoid malignancies.<br />
Blood 2000; 96: 71–75.<br />
33 Cazin B, Binet JL, Divine M, Lepretre S, Lederlin P, Travade P,<br />
Lemaire G, Guibon O. Oral fludarabine <strong>and</strong> <strong>cyclophosphamide</strong><br />
in previously untreated chronic lymphocytic leukemia. Blood<br />
2000; 96 (Suppl. 1): 515a (Abstr. 2218).<br />
34 O’Brien S, Kantarjian H, Beran M, Robertson LE, Freilich E,<br />
Kornblau S, Koller C, Estey E, Lerner S, KeatingM. Fludarabine<br />
<strong>and</strong> mitoxantrone therapy in chronic lymphocytic leukemia.<br />
Blood 1996; 88 (Suppl. 1): 588a (Abstr. 2341).<br />
35 Rummel MJ, Stilgenbauer S, Gamm H, Karakas T, Mitrou PS,<br />
Doelmer H, Hoelzer D, Bergmann L. Fludarabine versus fludarabine<br />
plus epi<strong>ru</strong>bicin in the treatment of chronic lymphocytic leukemia<br />
– preliminary results of a r<strong>and</strong>omized phase III multicenter<br />
study. Blood 2000; 96 (Suppl. 1): 2946 (Abstr. 5013).<br />
36 Bocchia M, Bigazzi C, Marconcini S, Forconi F, Marotta G, Algeri<br />
R, Lauria F, Favorable impact of low-dose fludarabine plus epi<strong>ru</strong>bicin<br />
<strong>and</strong> <strong>cyclophosphamide</strong> regimen (FLEC) as treatment for lowgrade<br />
non-Hodgkin’s lymphomas. <strong>Hem</strong>atologica 1999; 84: 716–<br />
720.<br />
37 Perales M, Bosch F, Esteve J, Fludarabine, <strong>cyclophosphamide</strong> <strong>and</strong><br />
mitoxantrone (FCM) in resistant or relapsed chronic lymphocytic<br />
leukemia <strong>and</strong> follicular lymphoma. Ann Oncol 1999; 10 (Suppl.<br />
3): 128 (Abstr. 462).<br />
38 Weiss M, Spiess T, Berman E, Kempin S. Concomitant administration<br />
of chlorambucil limits dose intensity of fludarabine in previously<br />
treated patients <strong>with</strong> chronic lymphocytic leukemia. Leukemia<br />
1994; 8: 1290–1293.<br />
39 Cheson BD. Infectious <strong>and</strong> immunosuppressive complications of<br />
purine analogtherapy. J Clin Oncol 1995; 13: 2431–2448.<br />
40 Anaissie EJ, Kontoyiannis DP, O’Brien S, Kantarjian H, Robertson<br />
L, Lerner S, KeatingMG. Infections in patients <strong>with</strong> chronic lymphocytic<br />
leukemia treated <strong>with</strong> fludarabine. Ann Intern Med 1998;<br />
129: 559–566.<br />
41 Betticher DC, von Rohr A, Ratschiller D, Schmitz SF, Egger T, Sonderegger<br />
T, Herrmann R, Kroner T, Zulian GB, Cavalli F, Fey MF,<br />
Cerny T. Fewer infections, but maintained antitumor activity <strong>with</strong><br />
lower-dose versus st<strong>and</strong>ard-dose cladribine in pretreated lowgrade<br />
non-Hodgkin’s lymphoma. J Clin Oncol 1998; 16: 850–858.<br />
42 O’Brien S, Kantarjian H, Beran M, Koller C, Talpaz M, Lerner S,<br />
KeatingMJ. Fludarabine <strong>and</strong> granulocyte colony-stimulatingfactor<br />
(G-CSF) in patients <strong>with</strong> chronic lymphocytic leukemia. Leukemia<br />
1997; 11: 1631–1635.<br />
43 Flinn IW, Byrd JC, Morrison C, Jamison J, Diehl LF, Murphy T,<br />
Piantadosi S, Seifter E, Ambinder RF, Vogelsang G, Grever MR.<br />
Fludarabine <strong>and</strong> <strong>cyclophosphamide</strong> <strong>with</strong> filgrastim support in<br />
patients <strong>with</strong> previously untreated indolent lymphoid malignancies.<br />
Blood 2000; 96: 71–75.<br />
44 Sudhoff T, ArningM, Schneider W. Prophylactic strategies to meet<br />
infectious complications in fludarabine treated CLL. Leukemia<br />
1997; 11: S38–41.<br />
45 Byrd JC, Hargis JB, Kester KE, Hospenthal DR, Knutson SW, Diehl<br />
LF. Opportunistic pulmonary infections <strong>with</strong> fludarabine in previously<br />
treated patients <strong>with</strong> low-grade lymphoid malignancies: a<br />
role for Pneumocystis carinii pneumonia prophylaxis. Am J <strong>Hem</strong>atol<br />
1995; 49: 135–142.<br />
46 Kalil N, Cheson BD. Management of chronic lymphocytic leukaemia.<br />
D<strong>ru</strong>gs Aging 2000; 16: 9–27.<br />
Leukemia